Location: Zurich, Switzerland
Deadline: 31 July 2026
About the Role As Associate Director, Patient Advocacy – Haemoglobinopathies, you will lead the execution of Novo Nordisk's patient advocacy strategy in this therapy area, ensuring that patient insights systematically inform evidence generation, access discussions and external engagement.
Responsibilities
Execute the approved patient advocacy strategy for hemoglobinopathies globally, translating strategic priorities into defined annual programs, measurable outcomes and clear accountability.
Manage a focused portfolio of priority patient advocacy organisations and patient leaders, develop annual partnership plans and deliver post-engagement summaries.
Operationally lead patient-informed evidence initiatives – including qualitative insights, real‑world evidence collaborations and advocacy‑led publications – ensuring outputs are publication‑ready and compliant.
Serve as the Corporate Affairs subject matter expert and reference point for patient‑informed insights, providing structured intelligence to inform decisions across Public Affairs, Medical, Market Access and Commercial.
Represent Novo Nordisk within selected advocacy and stakeholder forums relevant to hemoglobinopathies, aligned with annual engagement objectives and approved messaging frameworks.
Partner with Communications and Public Affairs to develop patient‑centric advocacy materials grounded in lived experience and compliant evidence standards.
Qualifications
Significant experience in patient advocacy, patient engagement or a closely related function within the pharmaceutical or biotech industry, preferably with rare diseases, hematology or haemoglobinopathies.
An established network within the haemoglobinopathy community or a proven track record of building credible relationships with patient advocacy organisations and patient leaders.
Proven ability to operationally lead patient-informed evidence initiatives, delivering publication‑ready outputs.
Strong cross‑functional collaboration skills, translating patient insights into structured intelligence for multiple stakeholders.
Excellent written and verbal communication skills in English, with knowledge of compliance, governance and ethical frameworks that guide patient advocacy engagement.
A relevant university degree in life sciences, public health, health policy, communications or a related discipline.
Benefits Benefits are designed with your career and life stage in mind, offering opportunities to learn, develop and make an impact across the patient journey.
Equal Opportunity Statement We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
#J-18808-Ljbffr
Deadline: 31 July 2026
About the Role As Associate Director, Patient Advocacy – Haemoglobinopathies, you will lead the execution of Novo Nordisk's patient advocacy strategy in this therapy area, ensuring that patient insights systematically inform evidence generation, access discussions and external engagement.
Responsibilities
Execute the approved patient advocacy strategy for hemoglobinopathies globally, translating strategic priorities into defined annual programs, measurable outcomes and clear accountability.
Manage a focused portfolio of priority patient advocacy organisations and patient leaders, develop annual partnership plans and deliver post-engagement summaries.
Operationally lead patient-informed evidence initiatives – including qualitative insights, real‑world evidence collaborations and advocacy‑led publications – ensuring outputs are publication‑ready and compliant.
Serve as the Corporate Affairs subject matter expert and reference point for patient‑informed insights, providing structured intelligence to inform decisions across Public Affairs, Medical, Market Access and Commercial.
Represent Novo Nordisk within selected advocacy and stakeholder forums relevant to hemoglobinopathies, aligned with annual engagement objectives and approved messaging frameworks.
Partner with Communications and Public Affairs to develop patient‑centric advocacy materials grounded in lived experience and compliant evidence standards.
Qualifications
Significant experience in patient advocacy, patient engagement or a closely related function within the pharmaceutical or biotech industry, preferably with rare diseases, hematology or haemoglobinopathies.
An established network within the haemoglobinopathy community or a proven track record of building credible relationships with patient advocacy organisations and patient leaders.
Proven ability to operationally lead patient-informed evidence initiatives, delivering publication‑ready outputs.
Strong cross‑functional collaboration skills, translating patient insights into structured intelligence for multiple stakeholders.
Excellent written and verbal communication skills in English, with knowledge of compliance, governance and ethical frameworks that guide patient advocacy engagement.
A relevant university degree in life sciences, public health, health policy, communications or a related discipline.
Benefits Benefits are designed with your career and life stage in mind, offering opportunities to learn, develop and make an impact across the patient journey.
Equal Opportunity Statement We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
#J-18808-Ljbffr
